Health
newsGP – Mixed response to latest Solidarity trial COVID findings – RACGP
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
News
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
While the results were disappointing, some experts say more detailed research is required. (Image: AAP)
Pre-print interim results from Solidarity, the world’s largest randomised control trial on COVID-19 therapeutics, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens have little or no effect on 28-day mortality or…
-
General19 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General21 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News21 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business18 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher